Caprock Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $14.5M | Sell |
|
|||||
|
2024
Q4 | $15.8M | Buy |
|
|||||
|
2024
Q3 | $17.7M | Buy |
|
|||||
|
2024
Q2 | $17.8M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Buy |
|
|||||
|
2023
Q4 | $1.17M | Buy |
|
|||||
|
2023
Q3 | $893K | Buy |
|
|||||
|
2023
Q2 | $888K | Buy |
|
|||||
|
2023
Q1 | $714K | Sell |
|
|||||
|
2022
Q4 | $669K | Buy |
|
|||||
|
2022
Q3 | $627K | Buy |
|
|||||
|
2022
Q2 | $598K | Sell |
|
|||||
|
2022
Q1 | $878K | Sell |
|
|||||
|
2021
Q4 | $751K | Buy |
|
|||||
|
2021
Q3 | $265K | Sell |
|
|||||
|
2021
Q2 | $364K | Buy |
|
|||||
|
2021
Q1 | $318K | Sell |
|
|||||
|
2020
Q4 | $388K | Sell |
|
|||||
|
2020
Q3 | $570K | Buy |
|
|||||
|
2020
Q2 | $541K | Buy |
|